Lv66
1890 积分 2023-12-21 加入
A novel anti-IL-33 antibody recognizes an epitope FVLHN of IL-33 and has a therapeutic effect on inflammatory diseases
2天前
已完结
A novel anti-IL-33 antibody recognizes an epitope FVLHN of IL-33 and has a therapeutic effect on inflammatory diseases
2天前
已完结
Basics of Clinical Drug Development: Clinical Trial and Drug Development
3天前
已完结
Skin‐infiltrating basophils promote atopic dermatitis‐like inflammation via IL‐4 production in mice
12天前
已完结
A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis
13天前
已完结
A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis
13天前
已完结
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
21天前
已完结
Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial
22天前
已完结
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial
28天前
已完结
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
29天前
已完结
皖公网安备34019202002308
